Trexquant Investment’s Astrana Health ASTH Stock Holding History

Trexquant Investment’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,874	Closed	-$658K	–	1796
2022 Q3	$658K	Buy	+16,874	New	+$772K	0.02%	691

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Trexquant Investment's ASTH Position: Q4 2022 in Review

Trexquant Investment sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 16,874 shares — an estimated $658K sold.

Trexquant Investment first reported a position in ASTH in Q3 2022 and held it in 1 quarter. The position peaked at $658K in Q3 2022. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

Trexquant Investment reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
Trexquant Investment sold 16,874 Astrana Health shares in Q4 2022, an estimated $658K.
Trexquant Investment first reported a position in Astrana Health in Q3 2022 and held it in 1 quarter.
Trexquant Investment's Astrana Health position peaked at $658K in Q3 2022.
130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.